Inovio (INO) Down More Than 30% in 3 Months: Here's Why - Nasdaq

Inovio (INO) Down More Than 30% in 3 Months: Here's Why  Nasdaq

Shares of Inovio Pharmaceuticals, Inc. INO have declined sharply in the past three months. The stock has plunged 33.1%, wider than the industry's.



Comments

Popular posts from this blog